Milestones in the Multiple Sclerosis Therapy Safety and efficacy

被引：0
|
作者：
Borchers, Anja
机构：
来源：
NERVENHEILKUNDE | 2010年 / 29卷 / 12期
关键词：
INTERFERON-BETA; FOLLOW-UP;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：861 / 861
页数：1
相关论文
共 50 条
  • [41] The safety and efficacy of modafinil in multiple sclerosis-related fatigue
    Thomas W. McAllister
    Current Psychiatry Reports, 2003, 5 (5) : 367 - 367
  • [42] Tetrahydrocannabinol in multiple sclerosis spasticity: efficacy and safety on everyday experience
    Chavarria Cano, Beatriz
    Luque Buzo, Elisa
    Pozo Crespo, David
    Prieto Alvarez, Juan
    Quintana Ortega, Cristian
    Pablo Cuello, Juan
    De Andres Frutos, Clara D.
    Martinez Gines, Maria Luisa
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 60 - 61
  • [43] The safety and efficacy of IFN-β products for the treatment of multiple sclerosis
    Kremenchutzky, Marcelo
    Morrow, Sarah
    Rush, Carolina
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (03) : 279 - 288
  • [44] The Efficacy and Safety of Manual Therapy for Symptoms Associated with Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Zhang, Tao
    Yan, Hui-Xin
    An, Yun
    Yin, Lu
    Sun, Ping-Ping
    Zhao, Jiang-Na
    Yan, Jun-Tao
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (10): : 780 - 790
  • [45] Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis
    Pulicken, M
    Bash, CN
    Costello, K
    Said, A
    Cuffari, C
    Wilterdink, JL
    Rogg, JM
    Mills, P
    Calabresi, PA
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 169 - 174
  • [46] Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy
    Goldschmidt, Carolyn H.
    Hua, Le H.
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2020, 10 : 29 - 38
  • [47] Effectiveness and Safety of Highly-Efficacy Therapy in Multiple Sclerosis: Systematic Review and Meta-Analysis
    Giraldo, L. P. Quintero
    Reyes, A. E. Martinez
    Montero, L. A. Zarco
    Velandia, O. M. Munoz
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 52 - 52
  • [48] Efficacy and safety of natalizumab as escalation and de-escalation therapy in relapsing-remitting multiple sclerosis
    Putzki, N.
    Kollia, K.
    Katsarava, Z.
    Weber, R.
    Igwe, E.
    Woods, S.
    Diener, H.
    MULTIPLE SCLEROSIS, 2007, 13 : S170 - S171
  • [49] Existing therapies for multiple sclerosis offer proven efficacy and safety
    Coyle, Patricia K.
    CURRENT OPINION IN NEUROLOGY, 2009, 22 : S4 - S9
  • [50] Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy
    Salzer, Jonatan
    Svenningsson, Rasmus
    Alping, Peter
    Novakova, Lenka
    Bjorck, Anna
    Fink, Katharina
    Islam-Jakobsson, Protik
    Malmestrm, Clas
    Axelsson, Markus
    Vagberg, Mattias
    Sundstrom, Peter
    Lycke, Jan
    Piehl, Fredrik
    Svenningsson, Anders
    NEUROLOGY, 2016, 87 (20) : 2074 - 2081
12345